“THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40%...

13
SESSION 4 A FOCUS ON CONCRETE INITIATIVES “THE EARLY INTERVENTION CLINIC IN SPAIN” PROF. JUAN A. JOVER HEAD OF RHEUMATOLOGY, HOSPITAL CLÍNICO SAN CARLOS COMPLUTENSE UNIVERSITY, MADRID

Transcript of “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40%...

Page 1: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

SESSION 4 – A FOCUS ON CONCRETE

INITIATIVES

“THE EARLY INTERVENTION CLINIC IN SPAIN”

PROF. JUAN A. JOVER

HEAD OF RHEUMATOLOGY, HOSPITAL

CLÍNICO SAN CARLOS

COMPLUTENSE UNIVERSITY, MADRID

Page 2: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

GLOBAL BURDEN OF DISEASE: CAUSES OF MORTALITY

2

Cancer

Cardiovascular

Page 3: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

GLOBAL BURDEN OF DISEASE: CAUSES OF DISABILITY

3

Cancer

Cardiovascular

Mental

Musculoskeletal

Page 4: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

4

MSDS: WHAT AILS YOU IS NOT WHAT KILLS YOU

MSD´s are the leading

cause of Work Disability

• First cause of Temporary

Work Disability

• First cause of Permanent

Work Disability

• MSDs diminish the

European economy by €240

billion

• 2% GDP loss every year

27 %

By 2030 50% of

the population of

some EU countries

will have an MSD

The major cause

of disability in

the EU

More than 200 Diseases, mostly chronic

What if…?

Page 5: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

24 months

Control

Early Intervention

Duration of TWD Evolution to PWD Patient´s satisfaction Economical Analysis

TWD

initiation

due to MSDs

(13.000

episodes)

Results

Randomisation

Results

A CLINICAL TRIAL IN MSD-TWD

Page 6: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

WHAT IS EARLY INTERVENTION?

An innovative care programme:

• Immediate specialist examination

• Early diagnosis

• Intense follow-up

• Support for return to work

• Targeted at MSD patients (who got a

sick note)

What patients will get:

• Expert clinical

management

• Protocolised Treatment

• Education

• Early mobilisation

• Stretching exercises

• Optimal levels of

physical activity

• Ergonomic notions

• Return-to-work support

Page 7: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

Control Intervention

Days

0

25

50

75

100

0 30 60 90 120 150 180 210 240 270 300 330 360

% of patients back to work

THE RETURN TO WORK OF THE E.I. CLINIC

Page 8: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

Patient

satisfaction

increased

With the care

they received

With the results

of the Programme

Return

to Work

Temporary work

disability

reduced by 39%

Permanent work

disability reduced

by 50%

Cost

Benefits

Decreased direct

costs by 40%

Decreased

indirect costs

by 39%

Return of €11

for every €1

invested

THE RESULTS

Page 9: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

WHY IT WORKS

Patient-focused

Expert assessment

&

Disability oriented

Integrated pathway

&

Rapid access

•Patient education

•Self–management

•One window system

•Confirmed diagnosis

•Focused on return to work

•GP referral to rheumatologists within 5 days of sickness absence

Page 10: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

EVERYBODY WINS WITH EARLY INTERVENTION

EI improves patient health and function, work ability and

work productivity.

EI eases their work, facilitating timely, accurate patient

flow,

diagnosis and treatment.

EI is a sustainable solution, increasing the efficiency

and effectiveness of the healthcare delivery.

It could be adjusted to manage other situations and chronic

conditions.

EI contributes to increased cost savings to the Social

Security System, as well as the national economy.

EI ensures the maintenance of optimal productivity levels

and

proper management of sickness absence and presenteeism.

Governments &

economies

Patient

Health

professionals

Health systems

Employers

Page 11: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

In the near future the EIC´s will be financed by the Social Security

FIT FOR WORK EARLY INTERVENTION CLINICS IN SPAIN

Page 12: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

Thank YOU!

(..and next steps)

Page 13: “THE EARLY INTERVENTION CLINIC IN SPAIN” Jover.pdf · Benefits Decreased direct costs by 40% Decreased indirect costs by 39% Return of €11 ... of sickness absence . EVERYBODY

%

improving

one point

in the

Disabilit

y Scale

0

25

50

75

100

0 30 60 90 120 150 180 210 240 270 300 330 360

Days

187 episodes

Mean Age: 80 years

Control Intervention

EARLY INTERVENTION IN MSD-RELATED DISABILITY

IN THE ELDERLY: A PILOT STUDY